AURKA and glioblastoma: Moreover, in a manner dependent on the transcription factors c-MYC and PGC1α treatment with Aurora kinase A inhibitors renders GBM cells highly oxidative and dependent on fatty acid oxidation that in turn mediates them to be susceptible to inhibitors of FAO in vitro and in vivo.